Tulunay, F. C. Et Al. 2004. The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study. Functional Neurology , vol.19, no.3 , 197-202.

Tulunay, F. C., ERGÜN, H., Gülmez, S. E., Özbenli, T., Özmenoǧlu, M., Boz, C., ... Erdemoglu, A. K.(2004). The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study. Functional Neurology , vol.19, no.3, 197-202.

Tulunay, F. Et Al. "The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study," Functional Neurology , vol.19, no.3, 197-202, 2004

Tulunay, F. C. Et Al. "The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study." Functional Neurology , vol.19, no.3, pp.197-202, 2004

Tulunay, F. C. Et Al. (2004) . "The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study." Functional Neurology , vol.19, no.3, pp.197-202.

@article{article, author={F. Cankat Tulunay Et Al. }, title={The efficacy and safety of dipyrone (Novalgin®) tablets in the treatment of acute migraine attacks: A double-blind, cross-over, randomized, placebo-controlled, multi-center study}, journal={Functional Neurology}, year=2004, pages={197-202} }